Sanofi: Information concerning the total number of voting rights and shares - December 2024
Werte in diesem Artikel
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)
Sanofi
a French société anonyme with a registered share capital of 2,526,245,442 €
Registered office : 46, avenue de la Grande Armée - 75017 Paris - France
Registered at the Paris Commercial and Companies Registry under number 395 030 844
Date | Total number of issued shares | Number of real voting rights (excluding treasury shares) | Theoretical number of voting rights (including treasury shares)* |
December 31, 2024 | 1,263,122,721 | 1,413,130,110 | 1,422,661,191 |
* Pursuant to article 223-11 of the Règlement général de l’Autorité des Marchés Financiers.
This information is also available on the internet website of Sanofi under « Regulated Information in France »:
https://www.sanofi.com/en/investors/sanofi-share-and-adrs/share-overview/shares-and-voting-rights/
Investor Relations Department e-mail: investor.relations@sanofi.com |
Attachment
Ausgewählte Hebelprodukte auf Sanofi
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Sanofi
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Sanofi S.A.
Analysen zu Sanofi S.A.
Datum | Rating | Analyst | |
---|---|---|---|
13:26 | Sanofi Outperform | Bernstein Research | |
12:51 | Sanofi Neutral | JP Morgan Chase & Co. | |
12:31 | Sanofi Buy | UBS AG | |
24.01.2025 | Sanofi Neutral | JP Morgan Chase & Co. | |
23.01.2025 | Sanofi Buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
13:26 | Sanofi Outperform | Bernstein Research | |
12:31 | Sanofi Buy | UBS AG | |
23.01.2025 | Sanofi Buy | UBS AG | |
07.01.2025 | Sanofi Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.01.2025 | Sanofi Outperform | Bernstein Research |
Datum | Rating | Analyst | |
---|---|---|---|
12:51 | Sanofi Neutral | JP Morgan Chase & Co. | |
24.01.2025 | Sanofi Neutral | JP Morgan Chase & Co. | |
16.01.2025 | Sanofi Neutral | JP Morgan Chase & Co. | |
17.12.2024 | Sanofi Neutral | JP Morgan Chase & Co. | |
03.12.2024 | Sanofi Neutral | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
18.12.2024 | Sanofi Sell | Deutsche Bank AG | |
17.12.2024 | Sanofi Sell | Deutsche Bank AG | |
06.12.2024 | Sanofi Sell | Deutsche Bank AG | |
03.12.2024 | Sanofi Sell | Deutsche Bank AG | |
28.10.2024 | Sanofi Sell | Deutsche Bank AG |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Sanofi S.A. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen